Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged 18 years or older, both male and female.
- People who have been diagnosed with non-small cell lung cancer (a specific type of lung cancer) confirmed by imaging scans and tissue testing, following recognised 2022 diagnostic guidelines.
- People whose lung cancer is at an advanced stage (classified as Stage III or Stage IV).
- People who are either newly diagnosed, have not responded to a first course of standard treatment, or are unable or unwilling to undergo standard treatments such as surgery or chemotherapy/radiotherapy.
- People with a physical functioning score showing they are reasonably able to carry out daily activities (confirm with trial site for exact score requirements).
- People whose doctors expect them to live for more than 3 months.
- People who are willing to sign a consent form and are expected to follow the trial requirements.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have previously had certain procedures directed at the tumour, such as radioactive seed implantation, tumour ablation, or a procedure called TACE.
- People who have widespread cancer that has spread beyond the lungs to multiple other areas of the body in a way that cannot be controlled, such as spread to the liver, bones, or brain.
- People who have had, or currently have, another unrelated cancer.
- People whose blood test results show low white blood cell counts, low platelet counts, or low haemoglobin (low red blood cell levels), below certain thresholds (confirm with trial site for exact values).
- People whose liver or kidney function is significantly reduced, based on specific blood test results (confirm with trial site for exact values).
- People with blood clotting problems, a known bleeding disorder, or who are currently on blood-thinning medication — except where bleeding is related to their lung cancer.
- People who have an active infection that requires antibiotic treatment.
- People with high blood pressure, diabetes, or heart disease that is not well controlled and is causing noticeable symptoms.
- People who are allergic to contrast dye (a substance sometimes used in medical imaging).
- People who are pregnant or currently breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8613938570175
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
PFS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.